If you have to compare Canada with its counterpart, the United States, in regard to designing and approving new and alternative drugs, what kinds of regulatory holdbacks do you face here in Canada as drug developers?
October 6th, 2025 / 12:50 p.m.
Conservative
Jagsharan Singh Mahal Conservative Edmonton Southeast, AB
If you have to compare Canada with its counterpart, the United States, in regard to designing and approving new and alternative drugs, what kinds of regulatory holdbacks do you face here in Canada as drug developers?
See context to find out what was said next.